MGA Drugs Pvt. Ltd.
WHO-GMP certified and EU-GMP compliance manufacturing campus serving sterile injectables, beta-lactams, cephalosporins, carbapenems, and institutional export supply requirements.
Facility Overview
Focused, independently licensed manufacturing blocks supported by shared pharmaceutical-grade infrastructure.
MGA Drugs operates a WHO-GMP and EU-GMP compliance multi-unit manufacturing campus in Jammu, India. Each unit is independently licensed, separately certified, and dedicated to a specific product category, helping ensure focused regulatory compliance and reducing cross-contamination risk.
Separate Manufacturing Blocks
Beta-lactams, cephalosporins, and general injectables are produced in dedicated manufacturing blocks
HEPA H14 Cleanrooms
Class A filling zones within Class B surroundings, built to EU Annex 1 standards with monitoring.
Independent QA Authority
Each manufacturing facility is supported by independent Corporate Quality Assurance oversight.
Export-Ready Documentation
COPP, CTD dossiers, stability data, and multi-language labelling support for 20+ countries.
Manufacturing Site
Sunvet Pharma Pvt. Ltd.
Village Upper Moginand,
District Sirmaur, Kala Amb,
Himachal Pradesh - 173030
(India)
MGA Drugs Pvt. Ltd.
Unit (I)
Khasra No. 122,
SIDCO Industrial Area,
Ghatti, Kathua,
Jammu & Kashmir (India)
MGA Drugs Pvt. Ltd.
Unit (II)
Khasra No. 123,
SIDCO Industrial Area,
Ghatti, Kathua,
Jammu & Kashmir (India)
Production Units
Each unit is independently licensed, separately certified, and dedicated to a specific product category.
Beta-Lactam & Penicillin Injectable Unit
A fully dedicated facility for penicillin-group antibiotics, engineered with negative-pressure environments, dedicated air-handling units, and specialist containment systems. Designed for beta-lactam sterile manufacturing with complete separation from all other product categories.
Cephalosporin & Carbapenem Injectable Unit
A separate, purpose-built unit for cephalosporin-class and carbapenem antibiotics. The facility features validated aseptic filling lines, independent cleanroom zoning, and full containment separation from beta-lactam and general injectable areas.
General Sterile Injectables
The general injectable manufacturing unit handles a broad portfolio of sterile small-volume parenterals including liquid vials, ampoules, and multi-dose formats for human pharmaceutical supply across Africa, CIS, ASEAN, and the Middle East.
Oral Solid Dosage Forms & Expansion Unit
This unit covers solid oral dosage form manufacturing and additional production capacity to support MGA Drugs' expanding domestic and international order book. Products include tablets, capsules, and dry syrup formulations.
Infrastructure & Technology
Manufacturing infrastructure is visible at every stage, from cleanroom air quality to data integrity protocols governing every batch record.
HEPA H14 Cleanrooms
Class A filling zones within Class B surroundings, built to EU Annex 1 aseptic standards with continuous particle monitoring and alert/action limit systems.
Aseptic Filling Lines
Fully automated lines across injectable units, with media-fill validation at defined intervals and filling and sealing performed under dedicated AHU areas.
Water for Injection
Multi-effect distillation WFI generation with continuously circulating, thermally sanitised distribution loops tested daily against IP/BP/USP specifications.
100% Visual Inspection
Every vial and ampoule passes automated and manual inspection. Reject data is documented, categorised, and reviewed by QA before batch release.
Environmental Monitoring
Structured monitoring covers air and surface microbial sampling, temperature and humidity logging, and differential pressure monitoring with QA trend analysis.
Depyrogenation Tunnels
Automated vial washing, depyrogenation, and sterilising-grade filtration ensure primary containers meet endotoxin and sterility requirements before filling.
Lyophilisation Support
Freeze-drying capability for sensitive sterile injectable formulations requiring controlled moisture removal and validated cycle parameters.
Validated HVAC & Pressure Cascades
Dedicated HVAC zoning, pressure differentials, and containment strategies support product segregation and aseptic manufacturing expectations.
Data Integrity Controls
Batch documentation, QC results, deviations, and release records are reviewed through QA-controlled documentation practices and audit-ready traceability.
Manufacturing Process: Raw Material to Batch Release
Every batch follows a validated, documented manufacturing process. No stage advances without documented QA clearance.
Incoming QC
Materials are sampled, tested against specifications, and formally approved by QA before production release.
Compounding
Formulation in classified areas with in-process pH, concentration, and bioburden checks at defined intervals.
Sterile Filling
Aseptic filling under Class A conditions with real-time environmental and particle monitoring.
Inspection & Labelling
100% visual inspection followed by validated label application, secondary packaging, and batch coding.
QA Batch Release
Independent QA reviews all records and QC results. Batch release occurs only when all criteria are satisfied.